Key facts: CHYM Posts Q3 Profit and 32% Revenue Growth; Targets Rise

Chime Financial (CHYM) reported Q3 2026 revenue of $718M, up 32% YoY, and EPS of $0.11, turning a profit from a loss last year. Analysts raised price targets: UBS to $34, JPMorgan to $40, Goldman Sachs to $43, and Wells Fargo to $42. The average target is $40.87, suggesting 37% upside from the Nov. 4 close.

Original reporting
Published Nov 6, 2026, 8:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 8:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: CHYM Posts Q3 Profit and 32% Revenue Growth; Targets Rise — source image
Decision brief

The 30-second read

$CHYMBullishMed
01

Why it matters

The earnings beat and raised targets provide a fresh catalyst for short‑term buying interest.

02

Market read

Earnings and target upgrades create a bullish short‑term outlook for CHYM.

03

What to watch

Potential regulatory scrutiny on neobanking models could temper long‑term gains.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

Chime Financial is a U.S. neobank that recently went public; the article summarizes its Q3 earnings and analyst target revisions.

Company-level read

Ticker impact

$CHYMBullishHigh confidence
Context

Chime Financial reported Q3 2026 revenue of $718M (+32% YoY) and posted net income, plus analysts raised price targets.

Expected impact

likely upward pressure as the market prices in stronger earnings and higher analyst targets

Evidence & confidence

Revenue growth and profitability exceed prior expectations, and multiple banks lifted price targets, indicating bullish sentiment.

Market effects

Positive earnings may lift other fintech peers as the sector shows growth momentum.

U.S. market sentiment could improve in early trading.

Limited to U.S. fintech space; no broad macro impact.

Counterpoint

If earnings guidance is modest relative to peers, the stock may already be priced in, limiting upside.

Key entities

  • Chime Financial

    U.S. neobank listed under ticker CHYM.

  • UBS

    Raised price target to $34.

  • JPMorgan

    Raised price target to $40.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.